Increased levels of P-gP have occasionally been observed in malignancies following exposure to chemotherapeutic drugs and high levels of P-gP expression have been found to predict disease relapse in Duke’s stage B2 (pT3N0M0) colon cancers [22]. This evidence concerns the gene PGP and colonic neoplasm.